Works matching AU Kako, Makoto

Results: 41
    1
    2
    3
    4

    HCV--RNA in Type 2 Autoimmune Hepatitis.

    Published in:
    1991
    By:
    • Miyakawa, Hiroshi;
    • Kako, Makoto;
    • Nagai, Kozo;
    • Kino, Kunihiko;
    • Iwabuchi, Shogo;
    • Miyachi, Kiyomitsu;
    • Okamoto, Hiroaki;
    • Mayumi, Makoto
    Publication type:
    Letter
    5

    Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis.

    Published in:
    Journal of Gastroenterology & Hepatology, 2002, v. 17, n. 11, p. 1198, doi. 10.1046/j.1440-1746.2002.02876.x
    By:
    • Miyake, Kazuhiko;
    • Tango, Toshiro;
    • Ota, Yasuhiko;
    • Mitamura, Keiji;
    • Yoshiba, Makoto;
    • Kako, Makoto;
    • Hayashi, Shigeki;
    • Ikeda, Yusei;
    • Hayashida, Norimasa;
    • Iwabuchi, Shogo;
    • Sato, Yuzuru;
    • Tomi, Toshiaki;
    • Funaki, Naoya;
    • Hashimoto, Naoaki;
    • Umeda, Tomoyuki;
    • Miyazaki, Jun;
    • Tanaka, Katsuaki;
    • Endo, Yasuo;
    • Suzuki, Hiroshi
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients.

    Published in:
    1998
    By:
    • Miyakawa, Hiroshi;
    • Matsushima, Hiroshi;
    • Narita, Yoichi;
    • Hankins, Raleigh W.;
    • Kitazawa, Eriko;
    • Fujikawa, Hirotoshi;
    • Kikuchi, Kentaro;
    • Matsushita, Masanao;
    • Abe, Kazuhiro;
    • Kawaguchi, Naomi;
    • Morizane, Toshio;
    • Kako, Makoto;
    • Miyakawa, H;
    • Matsushima, H;
    • Narita, Y;
    • Hankins, R W;
    • Kitazawa, E;
    • Fujikawa, H;
    • Kikuchi, K;
    • Matsushita, M
    Publication type:
    journal article
    18
    19
    20

    Esophageal Varices as an Independent Predictor of Fatal Outcomes after Balloon-Occluded Retrograde Transvenous Obliteration in Patients with Hepatic Encephalopathy.

    Published in:
    Digestive Diseases, 2024, v. 42, n. 6, p. 583, doi. 10.1159/000541660
    By:
    • Iwasaki, Shuichiro;
    • Uojima, Haruki;
    • Sakita, Shinya;
    • Masuda, Sakue;
    • Kubota, Kousuke;
    • Fujikawa, Tomoaki;
    • Okubo, Tomomi;
    • Setsu, Toru;
    • Itokawa, Norio;
    • Furuichi, Yoshihiro;
    • Arase, Yoshitaka;
    • Tukiyama, Toshiki;
    • Fujii, Kaoru;
    • Hidaka, Hisashi;
    • Atsukawa, Masanori;
    • Kagawa, Tatehiro;
    • Kako, Makoto;
    • Terai, Shuji;
    • Kusano, Chika
    Publication type:
    Article
    21

    The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency.

    Published in:
    Digestive Diseases, 2022, v. 40, n. 5, p. 625, doi. 10.1159/000521062
    By:
    • Shao, Xue;
    • Uojima, Haruki;
    • Arai, Taeang;
    • Ogawa, Yuji;
    • Setsu, Toru;
    • Atsukawa, Masanori;
    • Furuichi, Yoshihiro;
    • Arase, Yoshitaka;
    • Horio, Kazue;
    • Hidaka, Hisashi;
    • Nakazawa, Takahide;
    • Kako, Makoto;
    • Kagawa, Tatehiro;
    • Iwakiri, Katsuhiko;
    • Nakajima, Atsushi;
    • Terai, Shuji;
    • Tanaka, Yasuhito;
    • Koizumi, Wasaburo
    Publication type:
    Article
    22
    23

    Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.

    Published in:
    Digestive Diseases, 2021, v. 39, n. 3, p. 234, doi. 10.1159/000510692
    By:
    • Wada, Naohisa;
    • Uojima, Haruki;
    • Satoh, Takashi;
    • Okina, Sosei;
    • Iwasaki, Shuichiro;
    • Shao, Xue;
    • Takiguchi, Hayato;
    • Arase, Yoshitaka;
    • Itokawa, Norio;
    • Atsukawa, Masanori;
    • Miyazaki, Koji;
    • Hidaka, Hisashi;
    • Kako, Makoto;
    • Kagawa, Tatehiro;
    • Iwakiri, Katsuhiko;
    • Horie, Ryouichi;
    • Suzuki, Takahiro;
    • Koizumi, Wasaburo
    Publication type:
    Article
    24
    25

    Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma.

    Published in:
    Cancers, 2020, v. 12, n. 2, p. 293, doi. 10.3390/cancers12020293
    By:
    • Chuma, Makoto;
    • Uojima, Haruki;
    • Numata, Kazushi;
    • Hidaka, Hisashi;
    • Toyoda, Hidenori;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirose, Shunji;
    • Atsukawa, Masanori;
    • Itokawa, Norio;
    • Arai, Taeang;
    • Kako, Makoto;
    • Nakazawa, Takahide;
    • Wada, Naohisa;
    • Iwasaki, Shuitirou;
    • Miura, Yuki;
    • Hishiki, Satoshi;
    • Nishigori, Shuhei;
    • Morimoto, Manabu;
    • Hattori, Nobuhiro
    Publication type:
    Article
    26
    27
    28
    29

    Risk factors for loss of skeletal muscle mass in patients with cirrhosis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 5, p. 550, doi. 10.1111/hepr.13308
    By:
    • Sung, Ji Hyun;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Tanaka, Yoshiaki;
    • Wada, Naohisa;
    • Kubota, Kousuke;
    • Nakazawa, Takahide;
    • Shibuya, Akitaka;
    • Fujikawa, Tomoaki;
    • Yamanoue, Hiroki;
    • Kako, Makoto;
    • Koizumi, Wasaburo
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41